ClassID:

21647

A61K2300/00 - page 28 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#8101
20110224145
2011-09-15

Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells

#8102
20110223621
2011-09-15

COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS

#8103
20110223266
2011-09-15

BEVERAGE AND MEDICAMENT CONTAINING BAMBOO EXTRACT AS A MAIN INGREDIENT

#8104
20110223264
2011-09-15

Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins

#8105
20110223262
2011-09-15

Method of Enhancing Biological Activity of Plant Extracts

#8106
20110223261
2011-09-15

STABLE CLEANSER COMPOSITIONS CONTAINING SULFUR

#8107
20110223260
2011-09-15

Mazindol combination in the treatment of attention deficit/hyperactivity

#8108
20110223259
2011-09-15

Anti-viral pharmaceutical compositions

#8109
20110223252
2011-09-15

ELECTROLYTE PURGATIVE

#8110
20110223250
2011-09-15

MULTI-VITAMIN AND MINERAL NUTRITIONAL SUPPLEMENTS

#8111
20110223246
2011-09-15

DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE

#8112
20110223241
2011-09-15

COMBINATION METHODS AND COMPOSITIONS

#8113
20110223239
2011-09-15

SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS

#8114
20110223238
2011-09-15

Bisbenzamidines for the treatment of pneumonia

#8115
20110223197
2011-09-15

Mucosal and Systemic Immunization with Alphavirus Replicon Particles

#8116
20110223192
2011-09-15

METHODS FOR DELAYING THE ONSET AND/OR REDUCING THE SEVERITY OF METABOLIC SYNDROME

#8117
20110223191
2011-09-15

ANTI-CANCER NUTRACEUTICAL COMPOSITION

#8118
20110223167
2011-09-15

COMBINATION THERAPY USING RECEPTOR TYROSINE KINASE INHIBITORS AND ANGIOGENESIS INHIBITORS

#8119
20110223162
2011-09-15

Targeting PAX2 for the treatment of breast cancer

#8120
20110223161
2011-09-15

Targeting PAX2 for the treatment of breast cancer

#8121
20110223150
2011-09-15

Neutraceutical-Based Topical Anxiolytic Agent and Method of Use

#8122
20110223148
2011-09-15

Therapeutic/prophylactic agent for prostate cancer

#8123
20110223133
2011-09-15

Therapeutic agent for hematopoietic tumors

#8124
20110223130
2011-09-15

USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE

#8125
20110220155
2011-09-15

Neutral or alkaline medium chain peroxycarboxylic acid compositions and methods employing them

#8126
20110218504
2011-09-08

Stimulation of cartilage formation using reduced pressure treatment

#8127
20110218482
2011-09-08

Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin

#8128
20110218329
2011-09-08

ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES

#8129
20110218247
2011-09-08

Formulations of low dose diclofenac and beta-cyclodextrin

#8130
20110218243
2011-09-08

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE

#8131
20110218242
2011-09-08

Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions

#8132
20110218231
2011-09-08

Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases

#8133
20110218213
2011-09-08

Methods and Compositions for Treating or Preventing Symptoms of Hormonal Variations

#8134
20110218203
2011-09-08

Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

#8135
20110218195
2011-09-08

METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS AND DISEASES ASSOCIATED THEREWITH

#8136
20110218179
2011-09-08

Treatment of lupus nephritis using laquinimod

#8137
20110218174
2011-09-08

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#8138
20110218169
2011-09-08

Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia

#8139
20110218168
2011-09-08

SUBSTITUTED POLYAMINES AS INHIBITORS OF BACTERIAL EFFLUX PUMPS

#8140
20110218159
2011-09-08

METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2

#8141
20110218151
2011-09-08

SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DRIVATIVES THEREOF, UNDENATURED TYPE II COLLAGEN AND, OPTIONALLY, GLUCOSAMINE SULFATE

#8142
20110218143
2011-09-08

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

#8143
20110217759
2011-09-08

STRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS

#8144
20110217753
2011-09-08

INHIBITORS OF EXTRACELLULAR PROTEASES

#8145
20110217411
2011-09-08

Nutritional compositions with coated lipid globules

#8146
20110217402
2011-09-08

Probiotic Derived Non-Viable Material For Allergy Prevention And Treatment

#8147
20110217398
2011-09-08

Extract of aerial parts of oats harvested before ear emergence

#8148
20110217387
2011-09-08

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FIBROMYALGIA

#8149
20110217358
2011-09-08

COMPOSITIONS FOR THE PROPHYLAXIS AND TREATMENT OF DERMATOLOGICAL/MUCOSAL DISEASES, AND USES THEREOF

#8150
20110217354
2011-09-08

Mesoporous implants for administering substances and methods of producing implants

#8151
20110217353
2011-09-08

Mesoporous implants for administering substances and methods of producing implants

#8152
20110217344
2011-09-08

SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS

#8153
20110217313
2011-09-08

TREATMENT OF ORTHOPEDIC CONDITIONS

#8154
20110217299
2011-09-08

Targeting PAX2 for the treatment of breast cancer

#8155
20110217295
2011-09-08

TREATMENT OF LUPUS ARTHRITIS USING LAQUINIMOD

#8156
20110217290
2011-09-08

TREATMENT AND/OR PREVENTION OF PEANUT INDUCED ANAPHYLAXIS

#8157
20110217285
2011-09-08

Keratin biomaterials for treatment of ischemia

#8158
20110217280
2011-09-08

METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS

#8159
20110217278
2011-09-08

Medication and treatment for disease

#8160
20110217261
2011-09-08

Combination pharmaceutical agents as inhibitors of HCV replication

#8161
20110217252
2011-09-08

COMPOUND USEFUL FOR TREATING CELLULITE

#8162
20110217249
2011-09-08

Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds

#8163
20110217244
2011-09-08

Compositions and methods for enhancing immune response

#8164
20110213193
2011-09-01

Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier

#8165
20110213127
2011-09-01

METHODS FOR USING AND IDENTIFYING MODULATORS OF DELTA-LIKE 4

#8166
20110213090
2011-09-01

Side-chain crystallizable polymers for medical applications

#8167
20110213037
2011-09-01

Methods for concomitant administration of colchicine and macrolide antibiotics

#8168
20110213030
2011-09-01

External preparation for skin

#8169
20110213020
2011-09-01

Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria

#8170
20110213004
2011-09-01

Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor

#8171
20110212989
2011-09-01

THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ISOFLAVONES

#8172
20110212987
2011-09-01

METHOD OF REDUCING CNS AND GASTROINTESTINAL SIDE AFFECTS ASSOCIATED WITH LONG-TERM DEXTROMETHORPHAN/LOW-DOSE QUINIDINE COMBINATION THERAPY

#8173
20110212984
2011-09-01

Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence

#8174
20110212982
2011-09-01

Administration of Dipeptidyl Peptidase Inhibitors

#8175
20110212980
2011-09-01

COMBINATIONS FOR THE TREATMENT OF MIGRAINE

#8176
20110212978
2011-09-01

Combination of ZD6474 and Pemetrexed

#8177
20110212977
2011-09-01

P70 S6 KINASE INHIBITOR AND MTOR INHIBITOR COMBINATION THERAPY

#8178
20110212964
2011-09-01

Modulators of pharmacokinetic properties of therapeutics

#8179
20110212932
2011-09-01

Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation

#8180
20110212928
2011-09-01

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

#8181
20110212914
2011-09-01

STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND METHODS OF ANALYZING THEM

#8182
20110212908
2011-09-01

TOPICAL COMPOSITIONS AND THE USE THEREOF

#8183
20110212900
2011-09-01

METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PAIN ASSOCIATED WITH HEMATOPOIETIC CELL TRANSPLANTATION

#8184
20110212892
2011-09-01

AGENT FOR TREATMENT OF DIABETES

#8185
20110212888
2011-09-01

Diet and methods for improving learning capacity, mood and behavior in mammals

#8186
20110212216
2011-09-01

Composition and method for reducing blood glucose levels

#8187
20110212201
2011-09-01

Skin whitening composition containing chia seed extract

#8188
20110212198
2011-09-01

HANGOVER RELIEF BY COMPOSITIONS COMPRISING ORAL REHYDRATION SOLUTION

#8189
20110212193
2011-09-01

Herbal ointment for musculoskeletal and joint-related conditions

#8190
20110212192
2011-09-01

INGESTIBLES CONTAINING SUGAR AND CINNAMON OR GINSENG

#8191
20110212191
2011-09-01

Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng

#8192
20110212189
2011-09-01

GASTRORETENTIVE ORAL HIGH DOSE ZINC PREPARATIONS

#8193
20110212186
2011-09-01

COMPOSITION FOR TREATING AUTOIMMUNE DISORDERS

#8194
20110212176
2011-09-01

CICLOPIROX AND CYTARABINE FOR THE TREATMENT OF LEUKEMIC DISORDERS

#8195
20110212175
2011-09-01

COMBINATION PREPARATION COMPRISING ANGIOTENSIN-II-RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR

#8196
20110212172
2011-09-01

Administration of an adsorbent polymer for treatment of systemic inflammation

#8197
20110212167
2011-09-01

Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof

#8198
20110212138
2011-09-01

Sustained release formulations using non-aqueous carriers

#8199
20110212135
2011-09-01

Oligodeoxynucleotide and its use to induce an immune response

#8200
20110212131
2011-09-01

METHOD FOR ENHANCING AN IMMUNE RESPONSE

#8201
20110212108
2011-09-01

NEUREGULIN/ERBB SIGNALING AND INTEGRIN

#8202
20110212099
2011-09-01

METHODS OF MODULATING IL-22 AND IL-17

#8203
20110212091
2011-09-01

MATERIALS AND METHODS FOR INHIBITING CANCER CELL INVASION

#8204
20110212089
2011-09-01

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#8205
20110212082
2011-09-01

METHOD FOR PRODUCING TABLET COMPRISING NATURAL ALLICIN

#8206
20110212073
2011-09-01

Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs

#8207
20110212068
2011-09-01

METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE

#8208
20110212057
2011-09-01

Cycloundecadepsipeptide compounds and use of said compounds as a medicament

#8209
20110212055
2011-09-01

NEURODEGENERATIVE DISORDERS

#8210
20110212052
2011-09-01

METHODS AND COMPOSITIONS OF TREATING AND PREVENTING AUTOIMMUNE DISEASES

#8211
20110212050
2011-09-01

Side-chain crystallizable polymers for medical applications

#8212
20110212047
2011-09-01

Polymer Therapy for the Treatment of Chronic Microvascular Diseases

#8213
20110209699
2011-09-01

COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LIPOXYGENASE INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#8214
20110208162
2011-08-25

METHODS FOR PREVENTING AGGREGATION OF ADIPOSE STROMAL CELLS

#8215
20110208135
2011-08-25

INTRAVAGINAL DELIVERY SYSTEM AND PROCESS FOR MANUFACTURING IT

#8216
20110208116
2011-08-25

Gas mist pressure bath system

#8217
20110207937
2011-08-25

Compounds that inhibit (block) bitter taste in composition and methods of making same

#8218
20110207825
2011-08-25

Methods for concomitant administration of colchicine and macrolide antibiotics

#8219
20110207822
2011-08-25

COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY

#8220
20110207821
2011-08-25

Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis

#8221
20110207819
2011-08-25

Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients

#8222
20110207814
2011-08-25

Combination Therapy for Breast Cancer Treatment

#8223
20110207808
2011-08-25

Long-chain carboxychromanols and analogs for use as anti-inflammatory agents

#8224
20110207806
2011-08-25

Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care

#8225
20110207804
2011-08-25

COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC DISEASES

#8226
20110207787
2011-08-25

Antimicrobial compositions

#8227
20110207776
2011-08-25

Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists

#8228
20110207770
2011-08-25

PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT

#8229
20110207768
2011-08-25

PHARMACEUTICAL COMBINATION OF ANTIBACTERIAL AND ANTIFUNGAL CREAM

#8230
20110207760
2011-08-25

SN-38 COMPOSITIONS

#8231
20110207759
2011-08-25

METHOD FOR TREATMENT OF ATHEROSCLEROTIC DISEASE

#8232
20110207752
2011-08-25

P70 S6 kinase inhibitor and EGFR inhibitor combination therapy

#8233
20110207742
2011-08-25

METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE

#8234
20110207722
2011-08-25

TREATMENT OF ANXIETY DISORDERS

#8235
20110207718
2011-08-25

COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS

#8236
20110207711
2011-08-25

Therapeutic compounds

#8237
20110207696
2011-08-25

Compositions for treating rosacea

#8238
20110207694
2011-08-25

MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM

#8239
20110207693
2011-08-25

Oral B12 Therapy

#8240
20110207692
2011-08-25

Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine

#8241
20110207691
2011-08-25

COBALAMIN COMPOSITIONS FOR THE TREATMENT OF CANCER

#8242
20110207687
2011-08-25

Fulvic acid and antibiotic combination

#8243
20110207685
2011-08-25

Oral Formulations of Chemotherapeutic Agents

#8244
20110207684
2011-08-25

Low side effect pharmaceutical composition containing isoniazid

#8245
20110207679
2011-08-25

METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES

#8246
20110207673
2011-08-25

METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION

#8247
20110207666
2011-08-25

METHOD OF PROMOTING BONE GROWTH WITH HYALURONIC ACID AND GROWTH FACTORS

#8248
20110207665
2011-08-25

Method of regulating proliferation and differentiation of keratinocyes

#8249
20110207663
2011-08-25

Fibroblast growth factor (FGF) analogs and uses thereof

#8250
20110207658
2011-08-25

High purity lipopeptides

#8251
20110207005
2011-08-25

Fuel Cell System and Method for Operation of a Fuel Cell System

#8252
20110206792
2011-08-25

COMPOSITIONS COMPRISING VITAMINS

#8253
20110206790
2011-08-25

Antimicrobial Foamable Soaps

#8254
20110206788
2011-08-25

NOVEL HERBAL COMPOSITION

#8255
20110206787
2011-08-25

and iridoid based formulations

#8256
20110206786
2011-08-25

Acai and Iridoid Based Formulations

#8257
20110206782
2011-08-25

PIPERIDINE MODULATORS OF DOPAMINE RECEPTOR

#8258
20110206780
2011-08-25

MORPHINAN MODULATORS OF NMDA RECEPTORS, SIGMA1 RECEPTORS, SIGMA2 RECEPTORS, AND/OR A3B4 NICOTINIC RECEPTORS

#8259
20110206779
2011-08-25

Gastric ulcer therapeutic agent

#8260
20110206774
2011-08-25

Antipyrotic formulation for the treatment of epidermal burns

#8261
20110206770
2011-08-25

ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 MICRONS TO ABOUT 10 MICRONS

#8262
20110206766
2011-08-25

DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

#8263
20110206761
2011-08-25

STABLE DOSAGE FORMS OF ANTIHYPERTENSIVE AGENTS

#8264
20110206759
2011-08-25

CCR7 ligand delivery and co-delivery in immunotherapy

#8265
20110206756
2011-08-25

DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF

#8266
20110206755
2011-08-25

METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION

#8267
20110206743
2011-08-25

Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids

#8268
20110206722
2011-08-25

Pharmaceutical Composition For Purifying Blood Vessels And Preparation Method Thereof

#8269
20110206721
2011-08-25

FERMENTED SOY NUTRITIONAL SUPPLEMENTS INCLUDING MUSHROOM COMPONENTS

#8270
20110206699
2011-08-25

Methods for the treatment of graft-versus-host disease

#8271
20110206674
2011-08-25

Yersinia SPP. Polypeptides and Methods of Use

#8272
20110206673
2011-08-25

POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF

#8273
20110206666
2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#8274
20110206665
2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#8275
20110206662
2011-08-25

Anti-angiogenesis therapy for the treatment of ovarian cancer

#8276
20110206661
2011-08-25

TRIMETHOXYPHENYL INHIBITORS OF TYROSINE KINASE

#8277
20110206659
2011-08-25

METHODS AND TREATMENT FOR ALLERGIES AND INFLAMMATION ASSOCIATED WITH GASTROINTESTINAL DISEASES

#8278
20110206654
2011-08-25

Methods of Modulating Gastrointestinal Tract Flora Levels with Alkaline Phosphatase

#8279
20110206645
2011-08-25

Treatment of bone-related cancers using placental stem cells

#8280
20110206640
2011-08-25

Engineered synergistic oncolytic viral symbiosis

#8281
20110206637
2011-08-25

Antiviral agents

#8282
20110206636
2011-08-25

Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus

#8283
20110206635
2011-08-25

Uses of IL-12 in hematopoiesis

#8284
20110206622
2011-08-25

Effervescent compositions comprising phosphonates and methods related thereto

#8285
20110206617
2011-08-25

MODIFIED POLYSACCHARIDES FOR DRUG AND CONTRAST AGENT DELIVERY

#8286
20110205859
2011-08-25

Replaceable decorative cover for watches with digital display

#8287
20110202033
2011-08-18

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY

#8288
20110202025
2011-08-18

Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis

#8289
20110201994
2011-08-18

Methods to regulate polarization of excitable cells

#8290
20110201675
2011-08-18

ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors

#8291
20110201654
2011-08-18

THERAPEUTIC COMBINATION

#8292
20110201626
2011-08-18

4,6-diaminopyrimidine stimulators of soluble guanylate cyclase

#8293
20110201624
2011-08-18

Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients

#8294
20110201597
2011-08-18

METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA

#8295
20110201586
2011-08-18

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM

#8296
20110201582
2011-08-18

METHOD AND COMPOSITION FOR TREATMENT OF SKIN CONDITIONS

#8297
20110201579
2011-08-18

Method of Improving the Overall Health of a Patient by Application of Pregnenolone

#8298
20110201576
2011-08-18

Small molecule inhibitors of stat3 with anti-tumor activity

#8299
20110201572
2011-08-18

PHARMACEUTICAL COMPOSITION WITH GLYCOSAMINOGLYCANS AND USE THEREOF IN THE TREATMENT OF CHRONIC ULCERS

#8300
20110201571
2011-08-18

Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine

#8301
20110201568
2011-08-18

PHYOTOCHEMICAL COMPOSITION AND A PROCESS THEREOF

#8302
20110201565
2011-08-18

LUTEOLIN AND DIOSMIN/DIOSMETIN AS NOVEL STAT3 INHIBITORS FOR TREATING AUTISM

#8303
20110201558
2011-08-18

Anaplerotic Therapy for Alzheimer's Disease and the Aging Brain

#8304
20110201115
2011-08-18

METHOD AND APPARATUS FOR PRODUCTION OF A SKIN GRAFT AND THE GRAFT PRODUCED THEREBY

#8305
20110201104
2011-08-18

ANTIVIRAL AGENT AGAINST ANIMAL VIRUSES

#8306
20110200981
2011-08-18

Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells

#8307
20110200697
2011-08-18

Compositions for prophylaxis or treatment of cerebrovascular diseases, for improving memory impairment, or for protecting neuronal cells, containing ethanol extract from , and

#8308
20110200693
2011-08-18

INCREASING THE EFFICIENCY OF UTILIZATION OF INGESTED CREATINE

#8309
20110200690
2011-08-18

Compositions and methods for treating depression

#8310
20110200689
2011-08-18

METHODS FOR TREATING GLIOBLASTOMA WITH HERBAL COMPOSITIONS

#8311
20110200687
2011-08-18

BIFEPRUNOX MESYLATE MAINTENANCE DOSE COMPOSITIONS AND METHODS FOR USING THE SAME

#8312
20110200686
2011-08-18

COMPOSITIONS OF MODULATORS OF THE WNT/B-CATENIN PATHWAY AND AN N-CINNAMYL-N'BENZHYDRYL PIPERAZINE AND THEIR USE IN TREATING NEOPLASTIC CONDITIONS INCLUDING MALIGNANT MELANOMA

#8313
20110200675
2011-08-18

Drug delivery vehicles, methods of manufacture, and methods of use thereof

#8314
20110200673
2011-08-18

Oxidized heparin fractions and their use in inhibiting angiogenesis

#8315
20110200668
2011-08-18

PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS ASSOCIATED WITH ENTERAL ADMINISTRATION OF ANTIBIOTICS

#8316
20110200642
2011-08-18

Compositions and Methods to Promote Implantation and Engrafment of Stem Cells

#8317
20110200621
2011-08-18

Compositions and methods for treating cancer

#8318
20110200618
2011-08-18

ERBB4 INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROPSYCHIATRIC DISORDERS

#8319
20110200617
2011-08-18

COMBINATION THERAPY OF BETA-GLYCOLIPIDS AND ANTIBODIES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS

#8320
20110200613
2011-08-18

Use of B Cell Expansion Agents in Generating Antibodies

#8321
20110200610
2011-08-18

Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders

#8322
20110200598
2011-08-18

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR

#8323
20110200593
2011-08-18

Combination Therapy for the Treatment of Ocular Neovascular Disorders

#8324
20110200592
2011-08-18

Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist

#8325
20110200582
2011-08-18

LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM

#8326
20110200575
2011-08-18

Metallo-lactoferrin-coenzyme compositions to improve sleep patterns

#8327
20110200574
2011-08-18

USE OF PROTEASES FOR GLUTEN INTOLERANCE

#8328
20110200558
2011-08-18

Treatment or Prevention of Hepatitis C with Immunomodulator Compounds

#8329
20110200556
2011-08-18

CHEMOPREVENTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS

#8330
20110200554
2011-08-18

THERAPEUTIC AGENT FOR HEPATITIS C

#8331
20110196508
2011-08-11

CARTILAGE REPAIR MIXTURE CONTAINING ALLOGRAFT CHONDROCYTES

#8332
20110196383
2011-08-11

Atherosclerotic Plaque Dissolution Composition

#8333
20110196042
2011-08-11

Compositions and methods for influencing satiety, lipid metabolism, and fat utilization

#8334
20110196033
2011-08-11

Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient

#8335
20110196031
2011-08-11

Compositions and methods for treating varicose veins

#8336
20110196026
2011-08-11

COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY

#8337
20110196024
2011-08-11

Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases

#8338
20110196011
2011-08-11

Substituted arylpyrazoles

#8339
20110195989
2011-08-11

Controlled Release Formulations of Opioids

#8340
20110195987
2011-08-11

TREATMENT WITH CHOLINERGIC AGONISTS

#8341
20110195966
2011-08-11

COMBINATION OF A PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR AND A MTOR INHIBITOR

#8342
20110195953
2011-08-11

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

#8343
20110195952
2011-08-11

Treating psychological conditions using muscarinic receptor Mantagonists

#8344
20110195943
2011-08-11

NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR

#8345
20110195932
2011-08-11

Drug combinations for the treatment of duchenne muscular dystrophy

#8346
20110195926
2011-08-11

PURIFIED BETA GLUCAN COMPOSITION

#8347
20110195922
2011-08-11

Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B

#8348
20110195919
2011-08-11

COMBINATION THERAPY FOR ACNE VULGARIS COMPRISING ADMINISTRATION OF ADAPALENE 0.3% GEL AND CLINDAMYCIN/BENZOYL PEROXIDE GEL

#8349
20110195917
2011-08-11

Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate

#8350
20110195910
2011-08-11

USE OF TOCOTRIENOL COMPOSITION FOR THE PREVENTION OF CANCER

#8351
20110195898
2011-08-11

TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS

#8352
20110195436
2011-08-11

METHODS FOR THE CLASSIFICATION AND DIAGNOSIS OF SCOLIOSIS THROUGH THE USE OF GI PROTEIN RECEPTOR

#8353
20110195157
2011-08-11

Sustained release beads and suspensions including the same for sustained delivery of active ingredients

#8354
20110195156
2011-08-11

Sustained release beads and suspensions including the same for sustained delivery of active ingredients

#8355
20110195137
2011-08-11

Dermo-cosmetic composition for pets

#8356
20110195136
2011-08-11

Drop pill for treating coronary heart disease and preparation thereof

#8357
20110195133
2011-08-11

Dermcidin-derived peptides for lung cancer diagnostics

#8358
20110195096
2011-08-11

Compositions and methods for treating inflammatory disorders

#8359
20110195093
2011-08-11

Tissue targeted antigenic activation of the immune response to treat cancers

#8360
20110195075
2011-08-11

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

#8361
20110195071
2011-08-11

Therapy-enhancing glucan

#8362
20110195066
2011-08-11

QUINOLINE INHIBITORS OF TYROSINE KINASE

#8363
20110195061
2011-08-11

Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA

#8364
20110195058
2011-08-11

Cardiovascular support supplement and compositions and methods thereof

#8365
20110195050
2011-08-11

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT

#8366
20110195049
2011-08-11

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

#8367
20110195047
2011-08-11

ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS

#8368
20110195046
2011-08-11

ERYTHROPOIETIN AMELIORATES CHEMOTHERAPY-INDUCED TOXICITY IN VIVO

#8369
20110195042
2011-08-11

Compositions, Methods and Kits Useful for Treating a Respiratory Symptom

#8370
20110192748
2011-08-11

Administration of Dipeptidyl Peptidase Inhibitors

#8371
20110192269
2011-08-11

Portable stand and mount for securing a portable media or audio player to a support

#8372
20110190730
2011-08-04

METHODS OF INDUCING PLURIPOTENCY INVOLVING OCT4 PROTEIN

#8373
20110190729
2011-08-04

METHODS OF INDUCING PLURIPOTENCY INVOLVING SOX2 PROTEIN

#8374
20110190398
2011-08-04

USE OF IMMUNOSUPPRESSANT COMPOUNDS IN A NEW INDICATION

#8375
20110190397
2011-08-04

Methods for concomitant administration of colchicine and a second active agent

#8376
20110190396
2011-08-04

Methods for concomitant administration of colchicine and macrolide antibiotics

#8377
20110190389
2011-08-04

OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME

#8378
20110190356
2011-08-04

Compositions and Methods of Using (R)- Pramipexole

#8379
20110190348
2011-08-04

METHODS FOR TREATING CNS DISORDERS

#8380
20110190345
2011-08-04

Treatment of Psychosis with a 5HT2A Antagonist and a Metabotropic Glutamate Receptor Agonist or Potentiator

#8381
20110190314
2011-08-04

Pharmaceutical compositions and their methods of use

#8382
20110190312
2011-08-04

Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof

#8383
20110190311
2011-08-04

Use of CDK inhibitor for the treatment of glioma

#8384
20110190309
2011-08-04

PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST

#8385
20110190308
2011-08-04

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

#8386
20110190284
2011-08-04

AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS

#8387
20110190281
2011-08-04

Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis

#8388
20110190270
2011-08-04

METHODS OF TREATING THROMBOEMBOLIC DISORDERS

#8389
20110190253
2011-08-04

METHOD FOR TREATING TUBERCULOSIS

#8390
20110190252
2011-08-04

COMPOSITIONS INCLUDING CLAVULANIC ACID AND RELATED METHODS OF USE

#8391
20110190240
2011-08-04

Nuclear factor kappa B pathway inhibitor composition and use of same

#8392
20110190239
2011-08-04

BMI-1 protein expression modulators

#8393
20110190206
2011-08-04

Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade

#8394
20110190204
2011-08-04

Taxane- and taxoid-protein compositions

#8395
20110190199
2011-08-04

Combination Therapy for Tuberculosis

#8396
20110190192
2011-08-04

METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES

#8397
20110189771
2011-08-04

Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity

#8398
20110189669
2011-08-04

METHODS OF AIDING IN THE DIAGNOSIS OF PROSTATE CANCER

#8399
20110189337
2011-08-04

Compositions and methods for the prevention and treatment of metabolic diseases

#8400
20110189318
2011-08-04

METHODS FOR ENHANCING THE EXPRESSION OF INTRACELLULAR REDOX-ASSOCIATED FACTORS